Cargando…
Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators
Chronic inflammation has been implicated in the pathophysiology of major depressive disorder (MDD). Activating the resolution of inflammation through ω-3 fatty acid supplementation may prove to be a successful therapeutic strategy for the treatment of MDD. Patients with MDD, body mass index >25 k...
Autores principales: | Lamon-Fava, Stefania, Liu, Minying, Dunlop, Boadie W., Kinkead, Becky, Schettler, Pamela J., Felger, Jennifer C., Ziegler, Thomas R., Fava, Maurizio, Mischoulon, David, Rapaport, Mark Hyman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156711/ https://www.ncbi.nlm.nih.gov/pubmed/36635595 http://dx.doi.org/10.1038/s41386-022-01527-7 |
Ejemplares similares
-
Individuals with depression exhibiting a pro-inflammatory phenotype receiving omega-3 polyunsaturated fatty acids experience improved motivation-related cognitive function: Preliminary results from a randomized controlled trial
por: Mac Giollabhui, Naoise, et al.
Publicado: (2023) -
The United States index of socioeconomic deprivation for individuals (USiDep)
por: Dunlop, Boadie W., et al.
Publicado: (2022) -
Inflammation as a Predictive Biomarker for Response to Omega-3 Fatty Acids in Major Depressive Disorder: A Proof of Concept Study
por: Rapaport, Mark Hyman, et al.
Publicado: (2015) -
The prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical program
por: Waserstein, Gabriella, et al.
Publicado: (2019) -
Role of Specialized Pro-Resolving Mediators in Neuropathic Pain
por: Leuti, Alessandro, et al.
Publicado: (2021)